Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents.

Authors:
Preeti; Sambhakar S; Malik R; Bhatia S; Harrasi AA and 5 more

Journal:
Int J Hypertens

Publication Year: 2024

DOI:
10.1155/2024/2430147

PMCID:
PMC10896658

PMID:
38410720

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Hypertens

Abbreviation: Int J Hypertens

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Da-Chuan-Xiong Decoction Ameliorates Sodium Sensitivity and Plasma Norepinephrine via Attenuation o…
Zhang Q; Li H; Zhao S and 2 more (2024) - Transparency Score: 3/6
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms.
Qiu T; Jiang Z; Chen X and 2 more (2023) - Transparency Score: 3/6
Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis.
Hu H; Cao M; Sun Y and 3 more (2023) - Transparency Score: 3/6
Evaluation of Arterial Stiffness and Its Relation to Innovative Anthropometric Indices in Persian A…
Ataee Z; Aghaee A; Sobhani SR and 5 more (2023) - Transparency Score: 3/6
Evaluation of Mean Platelet Volume in Children with Hypertension.
Yildiz I; Kizilca O. (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest or personal ties that could have influenced the research presented in this study."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025